A detailed history of Epoch Investment Partners, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 1,962,030 shares of AZN stock, worth $140 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
1,962,030
Previous 2,289,057 14.29%
Holding current value
$140 Million
Previous $179 Million 14.36%
% of portfolio
0.71%
Previous 0.84%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $25.1 Million - $28.7 Million
-327,027 Reduced 14.29%
1,962,030 $153 Million
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $35.5 Million - $42.9 Million
-531,194 Reduced 18.83%
2,289,057 $179 Million
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $17,454 - $19,897
286 Added 0.01%
2,820,251 $191 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $6.39 Million - $7.15 Million
103,229 Added 3.8%
2,819,965 $190 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $6.22 Million - $6.88 Million
95,914 Added 3.66%
2,716,736 $184 Million
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $71.4 Million - $77.5 Million
1,021,770 Added 63.9%
2,620,822 $188 Million
Q1 2023

May 12, 2023

SELL
$63.15 - $71.6 $9.69 Million - $11 Million
-153,438 Reduced 8.76%
1,599,052 $111 Million
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $16.6 Million - $21.6 Million
-306,368 Reduced 14.88%
1,752,490 $119 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $3.03 Million - $7.76 Million
-57,131 Reduced 2.7%
2,058,858 $113 Million
Q2 2022

Aug 15, 2022

SELL
$59.26 - $71.14 $28.3 Million - $34 Million
-477,631 Reduced 18.42%
2,115,989 $140 Million
Q1 2022

May 13, 2022

SELL
$55.72 - $67.12 $7.54 Million - $9.09 Million
-135,389 Reduced 4.96%
2,593,620 $172 Million
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $56.6 Million - $66.9 Million
1,047,821 Added 62.33%
2,729,009 $159 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $9.05 Million - $9.9 Million
162,831 Added 10.72%
1,681,188 $101 Million
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $10.3 Million - $12.8 Million
212,591 Added 16.28%
1,518,357 $90.9 Million
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $8.31 Million - $9.6 Million
-176,259 Reduced 11.89%
1,305,766 $64.9 Million
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $917,076 - $1.1 Million
-18,901 Reduced 1.26%
1,482,025 $74.1 Million
Q3 2020

Nov 13, 2020

SELL
$53.07 - $61.1 $31.7 Million - $36.5 Million
-597,969 Reduced 28.49%
1,500,926 $82.3 Million
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $2.45 Million - $3.15 Million
-56,868 Reduced 2.64%
2,098,895 $111 Million
Q1 2020

May 14, 2020

SELL
$37.79 - $51.33 $1.07 Million - $1.45 Million
-28,296 Reduced 1.3%
2,155,763 $96.3 Million
Q4 2019

Feb 13, 2020

SELL
$42.46 - $50.46 $19 Million - $22.5 Million
-446,826 Reduced 16.98%
2,184,059 $109 Million
Q3 2019

Nov 13, 2019

SELL
$40.12 - $45.47 $40 Million - $45.3 Million
-995,837 Reduced 27.46%
2,630,885 $117 Million
Q2 2019

Aug 13, 2019

SELL
$37.28 - $41.68 $45.4 Million - $50.7 Million
-1,217,037 Reduced 25.13%
3,626,722 $150 Million
Q1 2019

May 14, 2019

SELL
$35.49 - $43.02 $42.2 Million - $51.1 Million
-1,188,193 Reduced 19.7%
4,843,759 $196 Million
Q4 2018

Feb 13, 2019

SELL
$36.86 - $41.49 $55.6 Million - $62.5 Million
-1,507,433 Reduced 19.99%
6,031,952 $229 Million
Q3 2018

Nov 13, 2018

SELL
$34.76 - $39.72 $18.1 Million - $20.7 Million
-521,912 Reduced 6.47%
7,539,385 $298 Million
Q2 2018

Aug 13, 2018

SELL
$34.55 - $37.05 $20.8 Million - $22.3 Million
-603,229 Reduced 6.96%
8,061,297 $283 Million
Q1 2018

May 14, 2018

SELL
$32.97 - $36.63 $11.6 Million - $12.9 Million
-352,353 Reduced 3.91%
8,664,526 $303 Million
Q4 2017

Feb 13, 2018

BUY
$32.09 - $34.78 $56.4 Million - $61.1 Million
1,756,338 Added 24.19%
9,016,879 $313 Million
Q3 2017

Nov 13, 2017

BUY
$28.96 - $34.0 $210 Million - $247 Million
7,260,541
7,260,541 $246 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $221B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Epoch Investment Partners, Inc. Portfolio

Follow Epoch Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.